BMS-345541 hydrochloride: Selective IKK Inhibitor for NF-κB Pathway and Inflammation Research

Executive Summary: BMS-345541 hydrochloride selectively inhibits IκB kinase isoforms IKK-1 and IKK-2, with IC₅₀ values of 4 μM and 0.3 μM, respectively, under standard in vitro assay conditions (APExBIO). It blocks NF-κB-dependent transcription, reducing expression of pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8 in both cell culture and animal models (Zhao et al. 2025). The compound does not inhibit unrelated kinases, ensuring pathway specificity. In T-ALL cell lines, it induces apoptosis and causes G2/M cell cycle arrest, supporting applications in cancer biology research. BMS-345541 hydrochloride is water-soluble (≥60 mg/mL), orally bioavailable (100% in animal models), and stable when stored at -20°C, making it suitable for reproducible NF-κB pathway studies (APExBIO).

Biological Rationale

The NF-κB signaling pathway is a master regulator of inflammation, immune response, and cell survival. Aberrant NF-κB activation is implicated in chronic inflammatory diseases and cancer, including T-cell acute lymphoblastic leukemia (T-ALL) (Zhao et al. 2025). IκB kinases (IKKs) phosphorylate IκB proteins, leading to their degradation and subsequent NF-κB nuclear translocation. Inhibition of IKK activity disrupts this cascade, suppressing expression of pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8. Selective IKK inhibitors like BMS-345541 hydrochloride enable precise modulation of the NF-κB pathway, facilitating research in inflammation, apoptosis, and cancer biology. Unlike broad-spectrum kinase inhibitors, BMS-345541 hydrochloride targets the IKK complex specifically, reducing off-target effects and enhancing experimental interpretability (APExBIO).

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride is an allosteric inhibitor of the IκB kinase (IKK) complex, composed primarily of the IKK-1 (IKKα) and IKK-2 (IKKβ) isoforms. The compound binds to a discrete allosteric site outside the ATP-binding pocket, selectively inhibiting kinase activity with IC₅₀ values of 4 μM for IKK-1 and 0.3 μM for IKK-2 (APExBIO). This prevents phosphorylation of IκB, thereby blocking its degradation and inhibiting NF-κB nuclear translocation. As a result, NF-κB-dependent transcription of pro-inflammatory genes is suppressed. BMS-345541 hydrochloride does not inhibit other serine/threonine or tyrosine kinases, ensuring high pathway selectivity. This mechanism is crucial for dissecting specific roles of IKK/NF-κB signaling in disease models and cell-based assays.

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 with an IC₅₀ of 4 μM under in vitro conditions (APExBIO).
• Reduces NF-κB-dependent transcription and pro-inflammatory cytokine expression (e.g., TNFα, IL-1β, IL-6, IL-8) in human and animal models (Zhao et al. 2025).
• Demonstrates no inhibitory activity against unrelated serine/threonine and tyrosine kinases at concentrations up to 100 μM (APExBIO).
• Induces apoptosis and G2/M phase arrest in T-ALL cell lines, supporting its use in chemoresistance studies (Precision IKK/NF-κB Pathway Modulation).
• Shows 100% oral bioavailability in rodent models, with effective suppression of TNFα production in vivo (APExBIO).
• Remains stable in aqueous solution when stored at -20°C for several months; insoluble in ethanol and DMSO (APExBIO).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is widely used in research on the IKK/NF-κB pathway, inflammation, and cancer biology. It is particularly valuable for dissecting NF-κB-mediated transcriptional programs and for studying apoptosis induction in T-ALL. The compound's high selectivity enables reliable inhibition of stimulus-induced IκB phosphorylation without broad kinase suppression, reducing confounding variables in cell-based and animal assays.

For a deeper mechanistic discussion, see Precision IKK/NF-κB Pathway Modulation, which extends the present article by offering strategic guidance and translational perspectives on BMS-345541 hydrochloride.

When compared to the workflow-focused guide at BMS-345541 Hydrochloride (SKU A3248): Reliable IKK Inhibitor, this article provides a more granular look at selectivity, mechanism, and application boundaries.

The scenario-driven discussion at BMS-345541 Hydrochloride (SKU A3248): Optimizing IKK/NF-κB complements this dossier with real-world lab examples, whereas here we focus on atomic, verifiable facts and evidence hierarchies.

Common Pitfalls or Misconceptions

• BMS-345541 hydrochloride does not inhibit kinases outside the IKK complex at relevant concentrations; off-target effects are minimal (APExBIO).
• It is not effective for studies requiring ethanol or DMSO solubilization; the compound is insoluble in these solvents.
• Long-term storage of prepared aqueous solutions at room temperature leads to degradation; always store at -20°C and use promptly.
• Not suitable for NF-κB-independent inflammation models, as its action is specific to IKK-mediated NF-κB activation.
• BMS-345541 hydrochloride is a research use only reagent and is not approved for clinical or therapeutic applications.

Workflow Integration & Parameters

BMS-345541 hydrochloride (APExBIO SKU A3248) is provided as a hydrochloride salt with high water solubility (≥60 mg/mL at room temperature). Dissolve in sterile water for cell culture or animal dosing. For in vitro work, recommended working concentrations range from 0.1 μM to 10 μM, depending on cell type and assay design. In animal studies, oral administration yields 100% bioavailability and robust suppression of TNFα production. Prepared stock solutions should be aliquoted and stored at -20°C. Avoid freeze-thaw cycles and prolonged storage at room temperature. The reagent is incompatible with ethanol and DMSO.

For ordering and full specifications, refer to the BMS-345541 hydrochloride product page from APExBIO. The company provides detailed documentation and batch-specific quality control data.

Conclusion & Outlook

BMS-345541 hydrochloride stands as a gold-standard selective IKK inhibitor for research on the NF-κB pathway, inflammation, and cancer biology. Its high specificity, water solubility, and reproducible performance make it ideal for dissecting the molecular underpinnings of cytokine signaling and apoptosis, particularly in T-ALL models. As highlighted by recent advances in anti-inflammatory drug development (Zhao et al. 2025), selective pathway modulation remains pivotal for new therapeutic approaches. Future work may extend the application of BMS-345541 hydrochloride to additional disease models and combinatorial strategies in inflammation and oncology research.